Iovance comes back with another upbeat cancer trial update as #ASCO19 curtain raiser
Iovance, one of the new darlings of the cancer set, pulled off the curtain raiser at ASCO with an update that offers another encouraging snapshot of progress and potential for its I/O drugs.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.